Befejeződött1. fázis
A study to investigate the safety and tolerability of dostarlimab in adult participants with chronic HBV infection on nucleos(t)ide analogue (NA) treatment
Key facts
- Where
- Palma, Santander és Sevilla, SpanyolországSee the 3 sites
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Spanyolország
- University Hospital Son EspasesPalma, SpanyolországNo longer taking part
- Hospital Universitario Marqués de ValdecillaSantander, SpanyolországNo longer taking part
- University Hospital Virgen Del Rocio S.L.Sevilla, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaxosmithkline Research & Development Limited
- Trial code
- EU 2023-509027-41-00
- Record updated
- 2024. november 15.